AbbVie Shares Close Down 4.6%, Sees Additional Humira Volume Erosion in 2Q
By Sabela Ojea Shares of AbbVie lost 4.6% to close at $159.62 on Friday after the company warned about the effects of losing the exclusivity of its patent for the arthritis medication Humira,...
Robert Michael Jeffrey Ryan Stewart Sabela Ojea North Chicago Chief Commercial Officer Jeffrey Ryan Stewart Executive Robert Michael
Source: marketscreener.com